Objectives-To investigate the feasibility of selective screening for abdominal aortic aneurysm (AAA) based on identification of a target group of manageable size defined by risk factors for AAA. Setting-Male residents of Perth, Western Australia, aged 65-83 years, who participated in a randomised controlled trial of ultrasound screening for AAA. Methods-Eligible men were identified from the electoral roll and invited to attend a screening clinic. Those who attended completed a questionnaire, had a limited physical examination, and underwent an ultrasound examination to identify the maximum diameter of the infrarenal aorta. Data on risk factors collected from the first 8995 men seen were used to calculate a multivariate risk score for the remaining 2755 men who were screened. Centiles of the risk score were used to define potential target groups for screening and the sensitivity and specificity of each of these selective screening strategies were calculated. We repeated the calculation separately for AAAs of at least 30 mm, 40 mm, and 50 mm in diameter. Results-We found that screening half of the male population aged 65-83 years would find approximately 75% of AAAs, regardless of their size, whereas screening only current smokers in this population would find approximately 20% of AAAs. Conclusions-Selective screening for AAA using easily recognisable risk factors is feasible but is not worthwhile as approximately 25% of clinically significant cases would be missed. (J Med Screen 2000;7:209-211) 
Ruptured abdominal aortic aneurysm (AAA) is fatal in unsuspecting elderly men and is becoming more common, resulting in sudden death in 80% of cases with more than 40% of these deaths occurring without admission to hospital. 1 As the majority of AAAs are asymptomatic prior to rupture, a logical approach to the problem is screening for and treating prevalent AAA. A beneficial impact of screening on mortality from AAA has not yet been demonstrated but this is being examined in several clinical trials.
Community based studies have established that screening using ultrasound is feasible and that men aged 65-75 years have the highest prevalence. 2 3 Following these reports a large number of hospital based studies reported the results of screening targeted "high risk" populations such as those with arterial vascular disease. 4 These investigations and subsequent analyses of community based data have yielded conflicting results on whether selective screening is likely to be more eVective than mass screening. [5] [6] [7] Although small AAA are not uncommon, clinically significant AAA (50 mm or more in diameter) are found in only 0.7% of elderly men attending for screening. 8 9 Furthermore, the risk of eventual rupture of small screen detected AAA appears to be very low. 10 Thus, despite response fractions of more than 70%, 8 9 alternative programmes that are more eYcient than population wide screening appear desirable. A cost eVective approach may be to limit screening to a subset of men at higher than average risk if such a group could be easily identified.
For example, the Canadian Task Force on the Periodic Health Examination has suggested that screening for AAA may be limited to men who are current smokers who also have other risk factors for the condition. 11 We examine the feasibility of selective screening by targeting a portion of the population at highest risk of AAA when a number of risk factors are taken into account.
Methods
Our data are based on results from the Western Australian AAA Program, which has been described in detail previously. 9 The programme is a population based trial of ultrasound screening of men in Perth, Western Australia, aged 65-83 years, who were apparently not resident in nursing homes when originally randomised to "screen" and "no screen" groups in April 1996. Men in the "screen" group were invited to attend a clinic where they were asked to complete a detailed questionnaire. Each underwent a limited physical examination (weight, height, girth, and blood pressure were measured), followed by ultrasound scan to establish the maximum diameter of the infrarenal aorta. Scans were performed by qualified ultrasonographers or specially trained nurses. Quality control exercises were conducted at regular intervals and included video recording of each man's scan for later checking of measurements, and assessment of inter-and intraobserver variation. Men for whom the aorta could not be visualised were recalled after an overnight fast.
Analysis of the data began with inspection of simple frequency tables followed by contingency tables using SAS, 12 in which men with an aortic diameter of 30 mm or more (cases) were compared with those with smaller aortic diameters (controls) across a range of 21 independent variables. Mutivariate models in which the outcome variable was case or control status were then developed using EGRET software. 13 This phase of the analysis is described in more detail elsewhere. 9 For the purposes of this paper, we used the odds ratios (ORs) from the most parsimonious multivariate model for the first 75% (n=8995) of men screened. This model consisted of 10 risk factors out of the 21 originally considered that had an independent and statistically significant contribution to the prediction of whether a given man had an AAA of 30 mm or more. The ORs from this model formed the basis of a risk score for the remaining 25% (n=2755) of men screened. The risk score was calculated as the sum of the natural logarithms (ln) of the ORs for each feature that a man had. These resulting risk scores varied between −0.8 and 4.2. Using the 95th centile of risk scores, we calculated the sensitivity and specificity of a selective screening strategy aimed at the 5% of men at highest risk of an AAA of 30 mm or more. We repeated this process for AAAs of 40 mm or more and for AAAs of 50 mm or more, as well as for target groups defined by the 90th, 85th, 80th, 75th, 66th, and 50th centiles of the risk score. An aortic diameter of 40 mm represents the smallest screen detected aneurysm for which radiological confirmation would routinely be sought, while one of 50 mm is the current threshold for elective surgical intervention in our community.
ETHICAL CONSIDERATIONS
The protocol for the trial of screening was approved by the human research ethics committee of the University of Western Australia.
Results
The prevalence of AAA of 30 mm or more among the first 8995 men who attended the screening was 7.8% compared with 2.4% for AAAs of 40 mm or more and 0.7% (7 per 1000) for those of 50 mm or more.
The multivariate logistic model of risk factors, which we derived from the first 8995 men who were screened, is shown in table 1. We used this model for calculation of the risk score for the last 2755 screened. There were significant graded relationships between AAA and age, height, and level of current smoking. There was a protective eVect associated with birth in the Mediterranean area, as well as with participating in regular physical exercise. There were excess risks in both current and ex-smokers but only 19.5% of AAAs of 30 mm or more occurred among the 10.8% of men who were current smokers. Men with known coronary disease and those with at least one sister with AAA also had an increased risk, as did those who reported being treated for hypertension or hypercholesterolaemia. Table 2 gives the sensitivity and specificity at the various centiles for each size of AAA, as well as the risk score which matched each of these centiles, for the 2755 men. Table 2 shows that by screening 50% of the male population aged 65-83 years of age, we would expect to find approximately 75% of AAAs, regardless of their size, whereas screening the 5% of this population at highest risk would find approximately 10% of AAAs.
Discussion
Our recent screening programme for AAA in Western Australia is one of three large population based controlled trials of screening for AAA currently in train 6 9 ; the MASS study in the UK has not yet been published. We achieved a corrected response fraction of 70.5%, showing that men are prepared to attend for ultrasound screening. However, the high cost of screening all men over 64 years of age has to be balanced against finding the few aneurysms that may warrant early intervention. Selective screening, based on the demographic, behavioural, and medical risk factors associated with AAA, is potentially a useful alternative approach. 5 The Canadian Task Force on the Periodic Health Examination suggested that ultrasound screening could be considered in selected high risk men over 60 years but they recommended limiting the selection to smokers who had other risk factors for AAA. 11 Our data show that if this principle were to be applied, 80% of aVected men would miss having their aneurysm detected due to the fact that they had never smoked or had given up smoking. In contrast, if screening was directed at all men who had ever smoked, 87% of AAAs might be found, but more than two thirds of the population would be tested, making this strategy relatively ineYcient.
Although smoking is strongly associated with AAA, this disease has multiple risk factors. 9 14 Another strategy would be to use a predictive score calculated from an array of factors associated with AAA. The conclusions from a large screening programme in Britain were that the only worthwhile selection criteria for screening were age and sex. 7 By contrast, our data suggest that a potential strategy would be to screen the half of the male population over 64 years of age who appear to be at the highest risk, as defined by consideration of 10 variables that could be identified by means of a short questionnaire. Men over 64 years of age could be routinely asked to complete this questionnaire by their general practitioner. Indeed, in an ideal situation, the relevant data would already be held on file. A risk score of 1.55 or more would indicate a "high risk" group and an ultrasound screening test would be recommended. This strategy would result in the diagnosis of more than 75% of AAAs of 40 mm or more. Unfortunately, it is likely that the healthiest cases, with the greatest potential to benefit from treatment, will be in the 50% with risk scores less than 1.55.
As part of our AAA screening programme, we are re-scanning annually all men found to have AAAs of 30-40 mm in diameter while those with AAAs of 40-50 mm are checked every six months. This phase of the project will assess rates and risk factors for expansion of small aneurysms and help to clarify which AAAs are likely to become clinically significant.
Meanwhile, our overall programme is yet to show that screening results in reduction of mortality from AAA. If it confirms that screening is useful, the present results indicate that an ongoing programme should be based on a whole population strategy as selective screening would miss 25% of AAAs. More data concerning the risk factors for expansion of small AAA may increase the prospects of selective screening.
